Filtros : "Current Pharmaceutical Design" "INFLAMAÇÃO" Limpar

Filtros



Refine with date range


  • Source: Current Pharmaceutical Design. Unidades: EEFERP, FORP

    Subjects: ANTIOXIDANTES, HIDROGÊNIO, INFLAMAÇÃO, FARMACOTERAPIA, ESTRESSE OXIDATIVO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      NOGUEIRA, Jonatas Evandro e BRANCO, Luiz Guilherme de Siqueira. Recent advances in molecular hydrogen research reducing exercise-induced oxidative stress and inflammation. Current Pharmaceutical Design, v. 27, n. 5, p. 731-736, 2021Tradução . . Disponível em: https://doi.org/10.2174/1381612826666201113100245. Acesso em: 16 nov. 2025.
    • APA

      Nogueira, J. E., & Branco, L. G. de S. (2021). Recent advances in molecular hydrogen research reducing exercise-induced oxidative stress and inflammation. Current Pharmaceutical Design, 27( 5), 731-736. doi:10.2174/1381612826666201113100245
    • NLM

      Nogueira JE, Branco LG de S. Recent advances in molecular hydrogen research reducing exercise-induced oxidative stress and inflammation [Internet]. Current Pharmaceutical Design. 2021 ; 27( 5): 731-736.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612826666201113100245
    • Vancouver

      Nogueira JE, Branco LG de S. Recent advances in molecular hydrogen research reducing exercise-induced oxidative stress and inflammation [Internet]. Current Pharmaceutical Design. 2021 ; 27( 5): 731-736.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612826666201113100245
  • Source: Current Pharmaceutical Design. Unidade: FCF

    Subjects: INFLAMAÇÃO, ARTERIOSCLEROSE, DOENÇAS CARDIOVASCULARES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARANHÃO, Raul Cavalcante e LEITE, Antonio Carlos de Arruda. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Current Pharmaceutical Design, v. 21, n. 9, p. 1196-1204, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612820666141013150714. Acesso em: 16 nov. 2025.
    • APA

      Maranhão, R. C., & Leite, A. C. de A. (2015). Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Current Pharmaceutical Design, 21( 9), 1196-1204. doi:10.2174/1381612820666141013150714
    • NLM

      Maranhão RC, Leite AC de A. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease [Internet]. Current Pharmaceutical Design. 2015 ; 21( 9): 1196-1204.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612820666141013150714
    • Vancouver

      Maranhão RC, Leite AC de A. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease [Internet]. Current Pharmaceutical Design. 2015 ; 21( 9): 1196-1204.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612820666141013150714

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025